Report Title:

External Review Procedure; Patients' Bill of Rights Law

Description:

Conforms the law to a recent Hawaii Supreme Court decision by amending the Patients' Bill of Rights external review procedure under which patients may appeal a managed care plan's final, internal decision denying coverage of a health intervention. Effective July 1, 2099. (HB395 HD2)

HOUSE OF REPRESENTATIVES

H.B. NO.

395

TWENTY-THIRD LEGISLATURE, 2005

H.D. 2

STATE OF HAWAII

 


 

A BILL FOR AN ACT

 

RELATING TO the patients' bill of rights.

 

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

SECTION 1. Under chapter 432E, Hawaii Revised Statutes, Hawaii's patients' bill of rights law, a patient who has been denied coverage for a health treatment by a health plan, or "managed care plan", has a right to an external review of that decision by a three-member panel, and the decision of the three-member panel is also subject to review in the state courts. Recently, the Hawaii State Supreme Court struck down this external review procedure in Hawaii Management Alliance Association v. Baldado, Slip Op. No. 24801, finding that the procedure was preempted by the federal Employee Retirement Income Security Act of 1974 (ERISA). As a result, patients with health plans subject to ERISA (private-sector employer-sponsored health plans) must challenge a denial of coverage by seeking arbitration or judicial review. But as these procedures are both expensive and time consuming, the patient may be unwilling or unable to challenge a health plan's final internal denial of coverage.

The legislature finds that a new external appeals process must be established to give patients who may be unreasonably denied coverage for medical treatment, access to a quick, inexpensive alternative method of appeal.

The purpose of this Act is to establish a new, non-judicial external review procedure by which patients may challenge a health plan's final, internal denial of coverage.

SECTION 2. Chapter 432E, Hawaii Revised Statutes, is amended by adding six new sections to be appropriately designated and to read as follows:

"§432E-A External review procedure; medical necessity. (a) Upon any adverse determination by a managed care plan that requires a medical necessity determination, and after exhausting all available internal complaint and appeal procedures, an enrollee, or the enrollee's treating licensed health care provider or appointed representative may request an external review to determine whether the adverse determination was consistent with the definition of medical necessity as defined in section 432E-1.4.

(b) A request for an external review shall be made and processed in the following manner:

(1) The enrollee shall submit the request to the commissioner within sixty days from the date of the managed care plan's final internal determination;

(2) The commissioner shall retain the services of no less than three independent review organizations through a bidding process, and refer external review requests to one of the independent review organizations on a rotating basis;

(3) The commissioner shall notify the managed care plan in writing of the request within fourteen days after receipt of the request for external review; provided that if the commissioner authorizes an expedited appeal pursuant to section 432E-6.5, the commissioner shall provide the required notice immediately upon receipt and approval of the request for expedited appeal;

(4) Within fourteen days of receipt of notice under paragraph (3) the managed care plan or its designee utilization review organization shall provide the independent review organization with:

(A) All medical records and supporting documentation pertaining to the case;

(B) A summary of the applicable issues, including a statement of the managed care plan’s decision and the criteria the managed care plan used to make its decision; and

(C) The medical and clinical reasons for the decision;

provided that if the external review is to be conducted as an expedited appeal, the managed care plan or its designee utilization review organization shall provide the independent review organization with the required information within forty-eight hours of receipt of notice under paragraph (3).

Upon request, the managed care plan shall also provide the information required by this paragraph to the enrollee or the enrollee's treating licensed health care provider or appointed representative;

(5) Within five business days after receipt of the information submitted by the managed care plan under paragraph (4), the independent review organization shall notify the enrollee or the enrollee's treating licensed health care provider or appointed representative of, and request any additional information that the expert reviewer requires. Within five business days of receipt of the request for additional information, the enrollee or the enrollee's treating licensed health care provider or appointed representative shall submit the additional information or an explanation as to why the additional information cannot be submitted.

Provided that if the external review is to be conducted as an expedited appeal, an independent review organization's request for additional information shall be made within twenty-four hours of receipt of the information required by paragraph (4) and shall allow the enrollee not less than forty-eight hours to provide the information;

(6) The expert reviewer appointed by the independent review organization shall review the final internal determination of the managed care plan to determine whether the managed care plan acted reasonably. The expert reviewer shall consider:

(A) The terms of the agreement of the enrollee's insurance policy, evidence of coverage, or similar document;

(B) Whether the medical director properly applied the medical necessity criteria in section 432E-1.4 in making the final internal determination;

(C) All relevant medical records and any other information provided;

(D) The treating licensed health care provider's recommendations;

(E) The clinical standards of the managed care plan; and

(F) Generally accepted practice guidelines;

and

(7) The independent review organization shall issue a written decision stating whether the managed care plan acted reasonably in denying coverage for the service or treatment on grounds of medical necessity. Such decision shall be sent to the enrollee or the enrollee's treating licensed health care provider or appointed representative, and the managed care plan within sixty days after receipt of the information required by paragraph (4); provided that the review that is the basis for the decision shall be conducted as soon as practicable, taking into consideration the medical exigencies of the case; provided further that if the external review is to be conducted as an expedited appeal, the decision shall be sent within forty-eight hours after receipt of the information required by paragraph (4) or, if additional information is requested under paragraph (5), not later than forty-eight hours after the earlier of the receipt of the additional information requested, or the end of the period afforded the enrollee to provide the additional information.

(c) The decision of an independent review organization made pursuant to this chapter shall be binding on the enrollee, the enrollee’s appointed representative, the treating licensed health care provider, and the managed care plan for purposes of the coverage to be provided to the enrollee by the managed care plan. If the expert reviewer determines the managed care plan did not act reasonably in concluding the health care service was not medically necessary, and the managed care plan has asserted no other basis for denying coverage, the managed care plan shall pay for the health care service.

(d) The managed care plan at its discretion may determine that additional information provided by the enrollee or the enrollee's treating licensed health care provider or appointed representative justifies a reconsideration of the decision to deny the coverage or reimbursement that is the subject of an external review. Upon notice to the enrollee or the enrollee's treating licensed health care provider or appointed representative, the commissioner, and the independent review organization, a decision by the managed care plan to grant the coverage or reimbursement based upon such reconsideration shall terminate the external review.

(e) The procedures set forth in this section shall not apply to claims or allegations of health provider malpractice, professional negligence, or other professional fault against participating providers.

§432E-B Disclosure and confidentiality of external review information. (a) Disclosure under section 432E-A of any health information protected by law shall be limited to disclosure for purposes relating to the external review.

(b) An independent review organization in receipt of information pursuant to section 432E-A shall maintain the confidentiality of:

(1) Medical records in accordance with state and federal law; and

(2) Proprietary information of the managed care plan.

§432E-C Liability under the external review procedure. (a) Nothing in this section shall be construed to:

(1) Create any private right or cause of action for or on behalf of any insured person; or

(2) Render the managed care plan liable for injuries or damages arising from any act or omission of the independent review organization or expert reviewer.

(b) Independent review organizations and their expert reviewers shall not be liable for injuries or damages arising from decisions made pursuant to section 432-A; provided that this subsection shall not apply to any act or omission by an independent review organization or expert reviewer that is made in bad faith or that involves gross negligence.

§432E-D Certification of independent review organizations; minimum standards. (a) The department of commerce and consumer affairs shall establish minimum standards for the certification of independent review organizations. An entity wishing to become certified by the department of commerce and consumer affairs shall demonstrate that it:

(1) Has no conflicts of interest under section 432E-F and is not owned, a subsidiary of, or an affiliate of a managed care plan or utilization review organization;

(2) Has the ability to maintain the confidentiality of medical records and other enrollee information, and the proprietary information of a managed care plan;

(3) Has complied with any national accreditation standards that pertain to independent review organizations; and

(4) Is registered, domiciled, and does the majority of its business outside of the state.

(b) Professional trade associations of health care providers or their subsidiaries or affiliates shall not be eligible for certification as an independent review organization.

§432E-E Expert reviewer qualifications. An expert reviewer shall be a physician and shall:

(1) Have no conflicts of interest under section 432E-F;

(2) Have expertise in the specific health condition of the enrollee whose appeal is under review and knowledge regarding the recommended service or treatment through actual clinical experience;

(3) Hold a unrestricted license to practice medicine in a state of the United States;

(4) Be currently certified by an American medical specialty board recognized by the American Osteopathic Association and the American Board of Medical Specialties in the areas appropriate to the subject of review; and

(5) Have no history of disciplinary action or sanctions related to quality of care, fraud, or other criminal activity.

§432E-F Conflicts of interest prohibited; disclosure. (a) Neither the expert reviewer nor the independent review organization shall have any relationship with the following entities or activities which may create a material, professional, familial, or financial conflict of interest related to the expert reviewer's or independent review organization's duties under this chapter:

(1) The managed care plan;

(2) Any officer, director, or management employee of the managed care plan;

(3) The physician, the physician’s medical group, or the independent practice association proposing the service or treatment subject to review;

(4) The institution at which the service or treatment would be provided;

(5) The development or manufacture of the principal drug, device, procedure, or other therapy proposed for the enrollee whose appeal is under review; or

(6) The enrollee or the enrollee's treating licensed health care provider or appointed representative who requested the review.

(b) A potential expert reviewer shall disclose any information regarding a potential conflict of interest to all parties to the review."

SECTION 3. Section 432E-6.5, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:

"(a) An enrollee may request that the following be conducted as an expedited appeal:

(1) The internal review under section 432E-5 of the enrollee's complaint; or

(2) [The external review under section 432E-6 of the managed care plan's final internal determination.] The external review under section 432E-A of the managed care plan's final internal determination.

If a request for an expedited appeal is approved by the managed care plan or the commissioner, the appropriate review shall be completed within seventy-two hours of receipt of the request for expedited appeal[.], except as otherwise provided in section 432E-A."

SECTION 4. Section 432E-6, Hawaii Revised Statutes, is repealed.

["§432E-6 External review procedure. (a) After exhausting all internal complaint and appeal procedures available, an enrollee, or the enrollee's treating provider or appointed representative, may file a request for external review of a managed care plan's final internal determination to a three-member review panel appointed by the commissioner composed of a representative from a managed care plan not involved in the complaint, a provider licensed to practice and practicing medicine in Hawaii not involved in the complaint, and the commissioner or the commissioner's designee in the following manner:

(1) The enrollee shall submit a request for external review to the commissioner within sixty days from the date of the final internal determination by the managed care plan;

(2) The commissioner may retain:

(A) Without regard to chapter 76, an independent medical expert trained in the field of medicine most appropriately related to the matter under review. Presentation of evidence for this purpose shall be exempt from section 91-9(g); and

(B) The services of an independent review organization from an approved list maintained by the commissioner;

(3) Within seven days after receipt of the request for external review, a managed care plan or its designee utilization review organization shall provide to the commissioner or the assigned independent review organization:

(A) Any documents or information used in making the final internal determination including the enrollee's medical records;

(B) Any documentation or written information submitted to the managed care plan in support of the enrollee's initial complaint; and

(C) A list of the names, addresses, and telephone numbers of each licensed health care provider who cared for the enrollee and who may have medical records relevant to the external review;

provided that where an expedited appeal is involved, the managed care plan or its designee utilization review organization shall provide the documents and information within forty-eight hours of receipt of the request for external review.

Failure by the managed care plan or its designee utilization review organization to provide the documents and information within the prescribed time periods shall not delay the conduct of the external review. Where the plan or its designee utilization review organization fails to provide the documents and information within the prescribed time periods, the commissioner may issue a decision to reverse the final internal determination, in whole or part, and shall promptly notify the independent review organization, the enrollee, the enrollee's appointed representative, if applicable, the enrollee's treating provider, and the managed care plan of the decision;

(4) Upon receipt of the request for external review and upon a showing of good cause, the commissioner shall appoint the members of the external review panel and shall conduct a review hearing pursuant to chapter 91. If the amount in controversy is less than $500, the commissioner may conduct a review hearing without appointing a review panel;

(5) The review hearing shall be conducted as soon as practicable, taking into consideration the medical exigencies of the case; provided that:

(A) The hearing shall be held no later than sixty days from the date of the request for the hearing; and

(B) An external review conducted as an expedited appeal shall be determined no later than seventy-two hours after receipt of the request for external review;

(6) After considering the enrollee's complaint, the managed care plan's response, and any affidavits filed by the parties, the commissioner may dismiss the request for external review if it is determined that the request is frivolous or without merit; and

(7) The review panel shall review every final internal determination to determine whether the managed care plan involved acted reasonably. The review panel and the commissioner or the commissioner's designee shall consider:

(A) The terms of the agreement of the enrollee's insurance policy, evidence of coverage, or similar document;

(B) Whether the medical director properly applied the medical necessity criteria in section 432E-1.4 in making the final internal determination;

(C) All relevant medical records;

(D) The clinical standards of the plan;

(E) The information provided;

(F) The attending physician's recommendations; and

(G) Generally accepted practice guidelines.

The commissioner, upon a majority vote of the panel, shall issue an order affirming, modifying, or reversing the decision within thirty days of the hearing.

(b) The procedure set forth in this section shall not apply to claims or allegations of health provider malpractice, professional negligence, or other professional fault against participating providers.

(c) No person shall serve on the review panel or in the independent review organization who, through a familial relationship within the second degree of consanguinity or affinity, or for other reasons, has a direct and substantial professional, financial, or personal interest in:

(1) The plan involved in the complaint, including an officer, director, or employee of the plan; or

(2) The treatment of the enrollee, including but not limited to the developer or manufacturer of the principal drug, device, procedure, or other therapy at issue.

(d) Members of the review panel shall be granted immunity from liability and damages relating to their duties under this section.

(e) An enrollee may be allowed, at the commissioner's discretion, an award of a reasonable sum for attorney's fees and reasonable costs incurred in connection with the external review under this section, unless the commissioner in an administrative proceeding determines that the appeal was unreasonable, fraudulent, excessive, or frivolous.

(f) Disclosure of an enrollee's protected health information shall be limited to disclosure for purposes relating to the external review."]

SECTION 5. In codifying the new sections added by section 2 of this Act, the revisor of statutes shall substitute appropriate section numbers for the letters used in designating the new sections in this Act.

SECTION 6. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.

SECTION 7. This Act shall take effect on July 1, 2099.